Compare SRFM & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRFM | SERA |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.7M | 79.5M |
| IPO Year | 2023 | 2021 |
| Metric | SRFM | SERA |
|---|---|---|
| Price | $1.13 | $2.03 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.25 | N/A |
| AVG Volume (30 Days) | ★ 3.7M | 21.4K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.69 | 32.32 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $106,557,000.00 | $81,000.00 |
| Revenue This Year | $25.90 | $554.81 |
| Revenue Next Year | $20.72 | $517.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $1.04 | $1.37 |
| 52 Week High | $9.35 | $4.09 |
| Indicator | SRFM | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 41.26 | 44.54 |
| Support Level | $1.07 | $1.91 |
| Resistance Level | $1.46 | $2.41 |
| Average True Range (ATR) | 0.13 | 0.17 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 15.38 | 26.72 |
Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.